Rebalance’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Rebalance’s Portfolio IBDS Stock Details IBDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.3M	Sell	714,290 -45,132	-6%	-$1.09M	0.91%	15
2026 Q1	$18.4M	Sell	759,422 -12,933	-2%	-$314K	1.07%	15
2025 Q4	$18.8M	Buy	772,355 +71,100	+10%	+$1.73M	1.1%	13
2025 Q3	$17.1M	Buy	701,255 +248,527	+55%	+$6.03M	1.03%	15
2025 Q2	$11M	Buy	452,728 +6,227	+1%	+$150K	0.75%	15
2025 Q1	$10.8M	Buy	446,501 +87,992	+25%	+$2.12M	0.8%	16
2024 Q4	$8.59M	Buy	+358,509	New	+$8.63M	0.64%	16

Other funds holding IBDS

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

SVWAG

Sound View Wealth Advisors Group Savannah, Georgia $1.61B AUM 26.11% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return

Rebalance's IBDS Position: Q2 2026 in Review

Rebalance reduced its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 5.9% in Q2 2026, selling an estimated $1.09M and leaving 714,290 shares worth $17.3M. The position accounts for 0.91% of the portfolio, ranked #15.

Rebalance first reported a position in IBDS in Q4 2024 and has held it in 7 quarters since. The position peaked at $18.8M in Q4 2025. 416 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

Rebalance held 714,290 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $17.3M as of Q2 2026.
Rebalance sold 45,132 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2026, an estimated $1.09M.
iShares iBonds Dec 2027 Term Corporate ETF made up 0.91% of Rebalance's portfolio in Q2 2026, its #15 holding.
Rebalance first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q4 2024 and has held it in 7 quarters since.
Rebalance's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $18.8M in Q4 2025.
416 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on Rebalance's 13F filing for Q2 2026, filed 16 Jul 2026.